AVP and autosomal dominant polycystic kidney disease: To investigate whether increased copeptin serum levels emerge from a reduced kidney clearance or as a compensation for diminished concentrating capacity, Zittema et al. (50) compared copeptin levels between 122 ADPKD patients and 134 healthy kidney donors (in whom total GFR decreases despite having a functionally normal kidney) before and after donation.